Using high and low avidity transgenic tumor reactive CD8+ T-cells specific for tyrosinase-related protein-2 (TRP2) we investigated how IL-2 alone or IL-12/IL-2 priming affected these two different T-cell populations. The gene discussed is IL2; the disease is neoplasm.